Medications

Cytisine not noninferior to varenicline for smoking cessation

(HealthDay)—Cytisine treatment fails to demonstrate noninferiority to varenicline treatment for smoking cessation, according to a study published in the July 6 issue of the Journal of the American Medical Association.

Medications

New study supports the safety of varenicline

A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix in the US and Champix elsewhere in the world) does not appear ...

Medications

Smoking cessation treatment targets adolescents

Preventable deaths are those that can be stymied by public health intervention, and deaths related to tobacco use are at the top of that list in the United States as well as globally.

page 2 from 5